FDANonrulemakingFDA-2024-D-2682

Who commented on this docket

Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

3 organizations filed 3 public comments on Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 679d ago.

Organizations
3
Comments
3
RIN
Comment window
closed 679d ago

Abstract

OPEN

Commenters (3)

  • American Academy of Pediatrics (AAP)
    1 filing · confidence 97%
  • Eli Lilly and Companyunverified attribution
    1 filing · confidence 70%
  • The European Society of Pediatric Gastroenterologytrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.